Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers

NYU Langone Health

Status: Not yet enrolling

Conditions: Cancer

Treatments: Behavioral: Visual Communication Tool

Study type: Interventional

Funder types: Other

Identifiers

NCT06927050

24-01870

Details and patient eligibility

About

This is a study in patients with newly diagnosed cancer to prospectively evaluate the feasibility of integration of a visual communication tool for patients/caregivers/providers by determining whether such a tool can increase overall satisfaction with the patient experience.

Enrollment: 86 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients:

• Patients seen in consultation from 12/1/2024-6/1/2025
• Patients aged 18 years to 100 years old
• Patients with a malignancy of breast or head and neck
• English speaking patients
• Patients being treated with definitive intent
• Patients treated at NYU Langone Health for their malignancy
• Willing and able to provide consent

Caregivers:

• Any adult caregiver(s) (aged 18 years to 100 years old) to a patient who fulfills the inclusion and exclusion criteria above.
• Willing and able to provide consent

Providers:

• Doctors and nurse practitioners in medical oncology and radiation oncology, and in the ear nose throat (ENT) department.
• Willing and able to provide consent
• aged 18 years to 100 years old

Exclusion criteria

Patients:

• Patients with any other site of disease other than listed above
• Non-English-speaking patients, as the tool is currently available in English only. Translation into additional languages such as Spanish and Russian is currently in process.
• Patient unable to complete the survey portion of the study independently

Caregivers:

• Unable to complete the survey portion of the study independently

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

86 participants in 1 patient group

Patients (and caregivers) recently diagnosed with cancer

Experimental group

Description:

Enrolled patients will receive a tool during the patient consultation encounter to explain their disease location and stage, role of radiation, logistics of radiation treatment delivery and sequencing of treatment. Following the encounter, a survey will be provided. If patients are accompanied by a caregiver(s), they will also receive a survey.

Treatment:

Behavioral: Visual Communication Tool